Enhanced CT and FDG PET/CT findings of splenic hamartoma

Clinical Nuclear Medicine

Volumn 39, Issue 11, 2014, Pages 968-971

  Dong, Aisheng ^a   Wang, Yang ^a   Lu, Jianping ^a   Zuo, Changjing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CT; FDG; PET CT; Spleen; Splenic hamartoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HAMARTOMA; HUMAN; LYMPHOCYTE; NOTE; PLASMA CELL; SPLEEN TUMOR; SPLENECTOMY; SPLENIC HAMARTOMA; AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MALE; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SPLEEN;

AGED; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HAMARTOMA; HUMANS; MALE; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SPLEEN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84927947563     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182a75ccc     Document Type: Note

References (17)

1. Lam KY, Yip KH, Peh WC. Splenic vascular lesions: unusual features and a review of the literature. Aust N Z J Surg. 1999;69:422-425.
2. Abbott RM, Levy AD, Aguilera NS, et al. From the archives of the AFIP: Primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. 2004;24:1137-1163.
3. Lee H, Maeda K. Hamartoma of the spleen. Arch Pathol Lab Med. 2009;133: 147-151.
4. Cheuk W, Lee AK, Arora N, et al. Splenic hamartoma with bizarre stromal cells. Am J Surg Pathol. 2005;29:109-114.
5. Wang JH, Ma XL, Ren FY, et al. Multi-modality imaging findings of splenic hamartoma: A report of nine cases and review of the literature. Abdom Imaging. 2013;38:154-162.
6. Yu RS, Zhang SZ, Hua JM. Imaging findings of splenic hamartoma. World J Gastroenterol. 2004;10:2613-2615.
7. Ramani M, Reinhold C, Semelka RC, et al. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology. 1997;202: 166-172.
8. Metser U, Even-Sapir E. The role of 18F-FDG PET/CT in the evaluation of solid splenic masses. Semin Ultrasound CT MR. 2006;27:420-425.
9. Metser U, Miller E, Kessler A, et al. Solid splenic masses: evaluation with 18F-FDG PET/CT. J Nucl Med. 2005;46:52-59.
10. Avila L, Sivaprakasam P, Viero S, et al. Splenic hamartoma in a child in the era of PET-CT. Pediatr Blood Cancer. 2009;53:114-116.
11. Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
12. Takata F, Kaida H, Ishibashi M, et al. Primary splenic lymphoma detected by F-18 FDG PET. Clin Nucl Med. 2008;33:204-207.
13. Soussan M, Pop G, Ouvrier MJ, et al. Diagnosis of synchronous isolated splenic metastasis from lung adenocarcinoma: complementary role of FDG PET/CT and diffusion-weighted MRI. Clin Nucl Med. 2011;36:707-709.
14. Abe T, Sato M, Okumura T, et al. FDG PET/CT findings of splenic angiosarcoma. Clin Nucl Med. 2009;34:82-83.
15. Thacker C, Korn R, Millstine J, et al. Sclerosing angiomatoid nodular transformation of the spleen: CT, MR, PET, and 99(m)Tc-sulfur colloid SPECT CT findings with gross and histopathological correlation. Abdom Imaging. 2010;35:683-689.
16. Feng YM, Huang YC, Tu CW, et al. Distinctive PET/CT features of splenic SANT. Clin Nucl Med. 2013. [Epub ahead of print].
17. Ahmadzadehfar H, Brockmann H, Schmiedel A, et al. Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT. Clin Nucl Med. 2008;33:571-572.